Whatever the outcome, our findings are in agreement with evidence demonstrating the importance of NF-kB in melanoma progression [55, 56], and the relevance of Bcl-2 and Bcl-xL to regulate cancer progression-associated properties through NF-kB. The gene discussed is BCL2L1; the disease is cancer.